Absci and invetx partner to bring generative ai drug creation platform to animal health

Collaboration leverages absci's leading generative ai drug creation models to design a novel antibody half-life extension (hle) platform for animal health applications collaboration leverages absci's leading generative ai drug creation models to design a novel antibody half-life extension (hle) platform for animal health applications
ABSI Ratings Summary
ABSI Quant Ranking